pmc logo image
Logo of westjmedJournal URL: http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=183&action=archive
Journal List > West J Med > v.121(2); Aug 1974

Formats:
West J Med. 1974 August; 121(2): 106–111.
PMCID: PMC1129514
Copyright notice
The Use of Propoxyphene Napsylate in the Treatment of Heroin and Methadone Addiction
Daryl S. Inaba, Pharm D, George R. Gay, MD, Craig A. Whitehead, MD, John A. Newmeyer, PH D, and Dan Bergin, BA
Haight-Ashbury Free Medical Clinics' Drug Detoxification, Rehabilitation, and Aftercare Project, San Francisco
Heroin Detoxification Ward, Aquarian Effort, Sacramento
Abstract
The use of methadone in the treatment of heroin addiction continues to be controversial. Propoxyphene napsylate (Darvon N®) is a possible alternative and a pilot study was conducted to test its acceptability, safety and clinical efficacy in treating long term, “multi-relapse” heroin addicts.
Findings indicate that propoxyphene napsylate suppresses many of the symptoms associated with opioid withdrawal phenomena. It should be viewed as a very promising therapeutic tool to be used in conjunction with psychological counseling and socio-vocational rehabilitation in detoxification and maintenance therapy for heroin or methadone addiction.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (982K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 106
106
icon of scanned page 107
107
icon of scanned page 108
108
icon of scanned page 109
109
icon of scanned page 110
110
icon of scanned page 111
111
 
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • DOLE VP, NYSWANDER M. A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE. JAMA. 1965 Aug 23;193:646–650. [PubMed]
  • Dole VP, Nyswander ME, Kreek MJ. Narcotic blockade. Arch Intern Med. 1966 Oct;118(4):304–309. [PubMed]
  • Dole VP, Nyswander ME, Warner A. Successful treatment of 750 criminal addicts. JAMA. 1968 Dec 16;206(12):2708–2711. [PubMed]
  • Dole VP, Robinson JW, Orraca J, Towns E, Searcy P, Caine E. Methadone treatment of randomly selected criminal addicts. N Engl J Med. 1969 Jun 19;280(25):1372–1375. [PubMed]
  • Aronow R, Paul SD, Woolley PV. Childhood poisoning. An unfortunate consequence of methadone availability. JAMA. 1972 Jan 17;219(3):321–324. [PubMed]
  • Emmerson JL, Owen NV, Koenig GR, Markham JK, Anderson RC. Reproduction and teratology studies on propoxyphene napsylate. Toxicol Appl Pharmacol. 1971 Jul;19(3):471–479. [PubMed]
  • Chambers CD, Moffett AD. Five patterns of darvon abuse. Int J Addict. 1971 Mar;6(1):173–189. [PubMed]
  • Wolfe RC, Reidenberg M, Vispo RH. Propoxyphene (Darvon) addiction and withdrawal syndrome. Ann Intern Med. 1969 Apr;70(4):773–776. [PubMed]
  • Tennant FS., Jr Complications of propoxyphene abuse. Arch Intern Med. 1973 Aug;132(2):191–194. [PubMed]
  • Fier M. Addiction to a massive dosage of Darvon: a case report. J Med Soc N J. 1973 May;70(5):393–395. [PubMed]
  • Owen NL. Abuse of propoxyphene. JAMA. 1971 Jun 21;216(12):2016–2016. [PubMed]
  • Salguero CH, Villarreal JE, Hug CC, Jr, Domino EF. Propoxyphene dependence. JAMA. 1969 Oct 6;210(1):135–136. [PubMed]
  • Mattson RH, Weisman GK, Levy LL. Dependence and central nervous system toxicity associated with the use of propoxyphene hydrochloride. Trans Am Neurol Assoc. 1969;94:299–301. [PubMed]
  • Sturner WQ, Garriott JC. Deaths involving propoxyphene. A study of 41 cases over a two-year period. JAMA. 1973 Mar 5;223(10):1125–1130. [PubMed]
  • Young DJ. Propoxyphene suicides. Report of nine cases. Arch Intern Med. 1972 Jan;129(1):62–66. [PubMed]
  • Hunt V. Treatment of dextropropoxyphene poisoning. Br Med J. 1973 Mar 3;1(5852):554–554. [PubMed]
  • Kersh ES. Treatment of propoxyphene overdosage with naloxone. Chest. 1973 Jan;63(1):112–114. [PubMed]
  • Bogartz LJ, Miller WC. Pulmonary edema associated with propoxyphene intoxication. JAMA. 1971 Jan 11;215(2):259–262. [PubMed]
  • Gary NE, Maher JF, DeMyttenaere MH, Liggero SH, Scott KG, Matusiak W, Schreiner GE. Acute propoxyphene hydrochloride intoxication. Arch Intern Med. 1968 May;121(5):453–457. [PubMed]
  • Gruber CM, Jr, Stephens VC, Terrill PM. Propoxyphene napsylate: chemistry and experimental design. Toxicol Appl Pharmacol. 1971 Jul;19(3):423–426. [PubMed]
  • Gay GR, Matzger AD, Bathurst W, Smith DE. Short-term heroin detoxification on an outpatient basis. Int J Addict. 1971 Jun;6(2):241–264. [PubMed]
  • McMahon RE, Ridolfo AS, Culp HW, Wolen RL, Marshall FJ. The fate of radiocarbon-labeled propoxyphene in rat, dog, and human. Toxicol Appl Pharmacol. 1971 Jul;19(3):427–444. [PubMed]
  • Kiplinger GF, Gruber CM, Jr, Pierce EC. A comparative study of the effects of chronic administration of propoxyphene salts to normal volunteers. Toxicol Appl Pharmacol. 1971 Jul;19(3):528–536. [PubMed]
  • Emmerson JL, Gibson WR, Harris PN, Todd GC, Pierce EC, Anderson RC. Short-term toxicity of propoxyphene salts in rats and dogs. Toxicol Appl Pharmacol. 1971 Jul;19(3):452–470. [PubMed]
Articles from The Western Journal of Medicine are provided here courtesy of
BMJ Group

PubMed articles by these authors